{
  "items": [
    {
      "title": "Akero Therapeutics: Where This Potential MASH Play Stands Currently",
      "description": "Discover the latest on Akero Therapeutics, Inc., a biotech firm focusing on metabolic balance therapies, with a market cap of $2 billion. Click for my AKRO update.",
      "published_utc": "2024-12-31T20:49:52",
      "source": "SeekingAlpha",
      "url": "https://finnhub.io/api/news?id=59f1490761432441566bcb1c76e1b8ca8e84060130f68c53918f19c2e06d32c5",
      "category": "company",
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/184964962/image_184964962.jpg?io=getty-c-w1536",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 132216255,
      "datetime": 1735649392
    },
    {
      "title": "This Biotech Is One of the S&P 500’s Worst Performers. It Looks Too Cheap.",
      "description": "This Biotech Is One of the S&P 500’s Worst Performers. It Looks Too Cheap.",
      "published_utc": "2024-12-31T08:01:00",
      "source": "MarketWatch",
      "url": "https://finnhub.io/api/news?id=372459c0450a0a8c44bad940edc33a0deb4f95ee859cf2bb4a3316f84f8972be",
      "category": "company",
      "image": "",
      "related_symbols": [
        "AMGN"
      ],
      "api_source": "finnhub_company",
      "id": 132324426,
      "datetime": 1735603260
    }
  ]
}